Mr. Christopher Cherry reports

MEDBRIGHT AI ANNOUNCES FILING OF APPLICATION FOR MANAGEMENT CEASE TRADE ORDER

Medbright AI Investments Inc. will likely miss its filing deadline of June 28, 2025, to file its audited annual financial statements, the accompanying management's discussion and analysis, and the related chief executive officer and chief financial officer certificates, for the financial year ended Feb. 28, 2025, as required under applicable Canadian securities laws.

In connection with the company's inability to file the annual filings on time, the company has applied for a management cease trade order (MCTO) under National Policy 12-203, Management Cease Trade Orders, and is waiting for the British Columbia Securities Commission approval.

The company is applying for a MCTO as a result of the company's change in auditor, which has necessitated a review of the prior year's audit work by the company's current auditor.

The company expects to file the annual filings on or about July 25, 2025, but in any event as soon as they are available and by no later than June 28, 2025. The company will issue a news release once the annual filings have been filed. Until the company files the annual filings, it will comply with the alternative information guidelines set out in NP 12-203. The guidelines, among other things, require the company to issue biweekly default status reports, in the form of news releases, for so long as the annual filings have not been filed.

During the MCTO, the general investing public will continue to be able to trade in the company's common shares listed on the Canadian Securities Exchange. However, the company's interim chief executive officer, chief financial officer, and such other directors, officers and persons, as determined by the applicable regulatory authorities, will not be able to trade in the company's common shares, nor will the company be able to, directly or indirectly, issue securities to or acquire securities from an insider or employee of the company except in accordance with legally binding obligations to do so existing as of June 28, 2025, being the date of the company's anticipated continuous disclosure default.

The company is not subject to any insolvency proceedings. If the company provides any information to any of its creditors during the period in which it is in default of filing the annual filings, the company confirms that it will also file material change reports on SEDAR+ containing such information.

About Medbright AI Investments Inc.

Medbright AI is a capital allocator focused on investing in diversified industries, including technology, health care and artificial intelligence. These include both public and private companies. Medbright has a focus on near-term and midterm high-quality opportunities with strong return potentials while maintaining its commitment to governance.

We seek Safe Harbor.